May 19, 2013 6:34 AM ET

Pharmaceuticals

Company Overview of Ischemix, Inc.

Company Overview

Ischemix, Inc., a pharmaceutical company, develops small molecule drugs for the treatment and prevention of ischemia-reperfusion injury. Its product includes CMX-2043, a cardio-protective drug that combines Akt pathway-mediated cell survival effects and anti-oxidant activity in a single small molecule, as well as is used for the prevention of peri-operative ischemia-reperfusion injury in patients undergoing elective percutaneous coronary intervention procedures. The company’s drugs also protect against the damaging effects associated with ischemia in brain and other organs. Ischemix, Inc. was formerly known as CereMedix, Inc. and changed its name to Ischemix, Inc. in February 2006. The compa...

Detailed Description

63 Great Road

Maynard, MA 01754

United States

Founded in 1999

Phone:

978-897-5139

Fax:

978-897-4952

www.ischemix.com

Key Executives for Ischemix, Inc.

Chief Executive Officer and President
Co-founder and Consultant
Age: 73
Vice President of Administration
Vice President of Research
Medical Director and Non-Executive Director
Compensation as of Fiscal Year 2012.

Ischemix, Inc. Key Developments

Ischemix, Inc. Presents at 2013 BIO International Convention, Apr-23-2013 02:45 PM
Apr 18 13

Ischemix, Inc. Presents at 2013 BIO International Convention, Apr-23-2013 02:45 PM. Venue: McCormick Place - Chicago Bulls Room, 2301 S. Lake Shore Drive, Chicago, IL 60616, United States.

Ischemix, Inc. Appoints David A. Dewahl as President and Chief Executive Officer
Jan 9 13

Ischemix, Inc. announced the appointment of David A. DeWahl, Jr. as President and Chief Executive Officer of the Company. Mr. DeWahl was previously a senior executive and co-founder, respectively, of Helix Therapeutics, Inc. and Life Science Pharmaceuticals, Inc. Prior to that he was an investment banker focused on the health care and life sciences industry for over 25 years.

Ischemix, Inc. Presents at 4th Annual International Partnering Conference, BioPharm America 2011, Sep-07-2011
Jul 13 11

Ischemix, Inc. Presents at 4th Annual International Partnering Conference, BioPharm America 2011, Sep-07-2011 . Venue: Westin Boston Waterfront Hotel, 425 Summer Street, Boston, MA 02210, United States.

Similar Private Companies By Industry

Company Name Region
Ortek Therapeutics Inc. United States
Met-Rx Substrate Technology, Inc. United States
Cabrellis Pharmaceuticals Corporation United States
Lilly Research Laboratories United States
Biotech United States

Recent Private Companies Transactions

Type
Date		 Target
No transactions available in the past 12 months.
Report Data IssueReport Data Issue
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ischemix, Inc., please visit www.ischemix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.

Close